 |
|
|
|
|
|
|
|
 |
 |
|
|
| |
At Oncolys, licensing is part of our core business strategy. We seek for the best ideas in science and licensing opportunities. We currently have active collaborations with several organizations, including academic institutions, scientists, research institutions and corporations. We strive to strengthen our product pipeline and deliver innovative therapeutics to enhance people's lives around the world.
Our current focus is on oncology and antiviral therapies. We are seeking to licensing early-stage compounds in the following areas:
Oncolytic virus (cancer therapies)
Antivirals
Please contact us with your product candidate and we will ensure that your opportunity receives a prompt yet comprehensive evaluation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
